業績

第47回日本神経内分泌学会　若手研究奨励賞　関崎　知紀先生

Kamoshima H, Nomoto H, Yamashita K, Takahashi Y, Tsuchida K, Kuwabara S, Miya A, Cho KY, Kameda H, Nakamura A, Atsumi T, Taneda S, Kurihara Y, Aoki S, Ono Y, Miyoshi H.

Do the benefits of sodium-glucose cotransporter 2 inhibitors exceed the risks in patients with type 1 diabetes?

Endocrine Journal, in press.

IF: 2.349

Oba-Yamamoto C, Takeuchi J, Nakamura A, Nomoto H, Kameda H, Cho KY, Atsumi T, Miyoshi H Impact of low-starch high-fiber pasta on postprandial blood glucose.

Nutrition, Metabolism and Cardiovascular Diseases, in press.

IF: 4.222

Kawata S, Nakamura A, Miyoshi H, Yang K, Shigesawa I, Yamauchi Y, Tsuchida K, Omori K, Takahashi K, Nomoto H, Kameda H, Cho KY, Terauchi Y, Atsumi T.

Glucokinase activation leads to an unsustained hypoglycaemic effect with hepatic triglyceride accumulation in db/db mice.

Diebetes Obes Metab, in press.

IF: 6.57

Chiba K, Kameda H, Miya A, Nomoto H, Cho KY, Nakamura A, Jin S, Matoba K, Miyoshi H, Atsumi T.

False hypercortisolemia due to abnormal albumin-cortisol binding in a patient with familial dysalbuminemic hyperthyroxinemia.

Thyroid, in press.

IF: 6.568

Kameda R, Cho KY, Nomoto H, Nakamura A, Omori K, Nagai S, Edagawa S, Kawata S, Takeuchi J, Kameda H, Kurihara Y, Aoki S, Atsumi T, Miyoshi H, LUNA Study Investigators.

Lowering of blood pressure and pulse rate by switching from DPP-4 inhibitor to luseogliflozin in patients with type 2 diabetes complicated with hypertension: a multicenter, prospective, randomized, open-label, parallel-group comparison trial (LUNA study) Diabetes Research and Clinical Practice, in press.

IF: 5.602

Nakamura A, Terauchi Y.

Impaired insulin secretion and related factors in East Asian individuals.

J Diabetes Investig, in press

IF: 3.761

Blencowe M, Furterer A, Wang Q, Gao F, Rosenberger M, Pei L, Nomoto H, Mawla AM, Huising MO, Coppola G, Yang X, Butler PC, Gurlo T.

IAPP induced beta cell stress recapitulates the islet transcriptome in type 2 diabetes Diabetologia, in press.

IF 10.122

Nakamura A, Omori K, Terauchi Y. Glucokinase activation or inactivation: Which will lead to the treatment of type 2 diabetes?
Diabetes Obes Metab, in press
IF: 5.900

Araki T, Tone Y, Yamamoto M, Kameda H, Ben-Shlomo A, Yamada S, Takeshita A, Yamamoto M, Kawakami Y, Tone M, Melmed S Two Distinctive POMC Promoters Modify Gene Expression in Cushing’s Disease J Clin Endocrinol Metab, in press.

IF:  5.399（英文・原著）